FinTrust Capital Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-57
Closed -$1K 1204
2022
Q3
$1K Sell
57
-254
-82% -$5.45K ﹤0.01% 1157
2022
Q2
$7K Buy
311
+21
+7% +$582 ﹤0.01% 965
2022
Q1
$11K Buy
290
+19
+7% +$740 ﹤0.01% 910
2021
Q4
$12K Hold
271
﹤0.01% 879
2021
Q3
$17K Sell
271
-5
-2% -$381 ﹤0.01% 773
2021
Q2
$25K Sell
276
-87
-24% -$6.92K 0.01% 696
2021
Q1
$25K Sell
363
-98
-21% -$7.61K 0.01% 658
2020
Q4
$33K Sell
461
-15
-3% -$869 0.01% 559
2020
Q3
$18 Buy
476
+362
+318% +$12.2K ﹤0.01% 670
2020
Q2
$4K Sell
114
-48
-30% -$1.37K ﹤0.01% 848
2020
Q1
$4K Buy
162
+83
+105% +$1.86K ﹤0.01% 895
2019
Q4
$2K Sell
79
-42
-35% -$964 ﹤0.01% 980
2019
Q3
$3K Buy
121
+45
+59% +$1.25K ﹤0.01% 933
2019
Q2
$3K Sell
76
-42
-36% -$1.34K ﹤0.01% 897
2019
Q1
$4K Sell
118
-27
-19% -$787 ﹤0.01% 966
2018
Q4
$4K Buy
+145
New +$3.73K ﹤0.01% 962

Other funds holding CDNA

FinTrust Capital Advisors's CDNA Position: Q4 2022 in Review

FinTrust Capital Advisors sold out of CareDx (CDNA) in Q4 2022, closing a stake of 57 shares — an estimated $1K sold.

FinTrust Capital Advisors first reported a position in CDNA in Q4 2018 and held it in 16 quarters. The position peaked at $33K in Q4 2020. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • FinTrust Capital Advisors reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 57 CareDx shares in Q4 2022, an estimated $1K.
  • FinTrust Capital Advisors first reported a position in CareDx in Q4 2018 and held it in 16 quarters.
  • FinTrust Capital Advisors's CareDx position peaked at $33K in Q4 2020.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on FinTrust Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.